All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2007-007027-40||A Multicenter open-label, phase I/II dose escalation study of oral lapatinib in combination with docetaxel in patients with HER2 positive advanced or metastatic breast cancer||not-yet-due|
|Ongoing||2008-002775-28||Evaluation de l'association irinotécan/bévacizumab utilisée en néo-adjuvant et en adjuvant d'une radiochimiothérapie avec témozolomide concomitant pour les glioblastomes non résécables. Etude de phase...||not-yet-due|
|Ongoing||2015-004108-44||PREMETHEP : Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an early predictive factor of overall survival in patients with advanced hepa...||not-yet-due|
|Ongoing||2016-002552-24||Pemetrexed (Alimta®) in maintenance in patients with impaired renal function: multicenter randomized Phase 4 study comparing two strategies for dose calculation Pemetrexed (Alimta®) en maintenance ...||not-yet-due|
|Ongoing||2019-003627-38||18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/CT for the detection of lesions in patients with multiple myeloma 18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/C...||not-yet-due|